Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 618
5
Diseases
3
Unique genes
0.375
Avg. similarity score
Combined psap deficiency
Most-connected disease (4 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Combined psap deficiency
Combined saposin deficiency
Gaucher disease due to saposin C deficiency
Krabbe disease
Krabbe disease due to saposin A deficiency
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Combined psap deficiency | 4 | 4 | 1 |
| Combined saposin deficiency | 4 | 4 | 2 |
| Gaucher disease due to saposin C deficiency | 4 | 4 | 1 |
| Krabbe disease | 4 | 4 | 2 |
| Krabbe disease due to saposin A deficiency | 4 | 4 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| PSAP | 5 / 5 | Combined psap deficiency, Combined saposin deficiency, Gaucher disease due to saposin C deficiency, Krabbe disease and 1 more |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Glycosphingolipid metabolism | Reactome | 2 / 46 | 174× | 4.30e-5 | 9.70e-4 ✓ sig. |
| Sphingolipid metabolism | KEGG | 2 / 54 | 148× | 5.94e-5 | 1.25e-3 ✓ sig. |
| Lysosome | KEGG | 2 / 133 | 60.2× | 3.63e-4 | 5.21e-3 ✓ sig. |
| Peptide ligand-binding receptors | Reactome | 1 / 106 | 37.8× | 2.62e-2 | 1.00e-1 |
| Platelet degranulation | Reactome | 1 / 123 | 32.5× | 3.04e-2 | 1.09e-1 |
| G alpha (i) signalling events | Reactome | 1 / 249 | 16.1× | 6.09e-2 | 1.62e-1 |
| Neutrophil degranulation | Reactome | 1 / 480 | 8.3× | 1.15e-1 | 2.35e-1 |
| Metabolic pathways | KEGG | 1 / 1,563 | 2.6× | 3.42e-1 | 4.72e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| sphingolipid metabolic process | GO:0006665 | 2 / 59 | 211× | 2.93e-5 | 1.23e-3 ✓ sig. |
| positive regulation of beta-galactosidase activity | GO:1903771 | 1 / 1 | 6,229× | 1.61e-4 | 4.34e-3 ✓ sig. |
| ganglioside GM1 transport to membrane | GO:1905572 | 1 / 1 | 6,229× | 1.61e-4 | 4.34e-3 ✓ sig. |
| galactosylceramide catabolic process | GO:0006683 | 1 / 2 | 3,115× | 3.21e-4 | 7.04e-3 ✓ sig. |
| epithelial cell differentiation involved in prostate gland development | GO:0060742 | 1 / 5 | 1,246× | 8.03e-4 | 1.28e-2 ✓ sig. |
| equilibrioception | GO:0050957 | 1 / 6 | 1,038× | 9.63e-4 | 1.42e-2 ✓ sig. |
| prostate gland growth | GO:0060736 | 1 / 8 | 779× | 1.28e-3 | 1.67e-2 ✓ sig. |
| glycosphingolipid catabolic process | GO:0046479 | 1 / 12 | 519× | 1.93e-3 | 2.07e-2 ✓ sig. |
| sensory perception of light stimulus | GO:0050953 | 1 / 13 | 479× | 2.09e-3 | 2.17e-2 ✓ sig. |
| cell-cell adhesion via plasma-membrane adhesion molecules | GO:0098742 | 1 / 18 | 346× | 2.89e-3 | 2.55e-2 ✓ sig. |
| inner ear auditory receptor cell differentiation | GO:0042491 | 1 / 19 | 328× | 3.05e-3 | 2.62e-2 ✓ sig. |
| auditory receptor cell stereocilium organization | GO:0060088 | 1 / 19 | 328× | 3.05e-3 | 2.62e-2 ✓ sig. |
| inner ear receptor cell stereocilium organization | GO:0060122 | 1 / 25 | 249× | 4.01e-3 | 3.01e-2 ✓ sig. |
| lysosomal transport | GO:0007041 | 1 / 26 | 240× | 4.17e-3 | 3.06e-2 ✓ sig. |
| cochlea development | GO:0090102 | 1 / 35 | 178× | 5.61e-3 | 3.51e-2 ✓ sig. |